Glycerophosphate

Phosthenine Ampoules

50 MG / AMP + 2 MG / AMP + 200 MG / AMP LiquidCanadaCancelledAuthorised 31 Dec 1979

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

GlycophosBrazil · Fresenius Kabi Brasil LtdaSame substance
NovophosBrazil · Vasconcelos Industria Farmaceutica e Comercio LtdaSame substance
Glycophos 216 MG/ML Concentrado Para Solución Para PerfusiónSpain · 216 mg · solución inyectable · Fresenius Kabi España, S.A.U.Same substance
GlycophosItaly · Concentrato per soluzione per infusione · Fresenius Kabi Italia S.R.L.Same substance
GLYCOPHOS 216 mg/mlRomania · 216mg/ml · conc. pt. sol. perf. · Fresenius Kabi ABSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Glycerophosphate

Phosthenine Ampoules

50 MG / AMP + 2 MG / AMP + 200 MG / AMP LiquidCanadaCancelledAuthorised 31 Dec 1979

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

GLYCOPHOS 216mg/ml

Romania · 216mg/ml · conc. pt. sol. perf. · Fresenius Kabi AB

GlycophosSaudi Arabia · Fresenius Kabi Norge As

Glycophos 216MG/MLSaudi Arabia · Fresenius Kabi Norge As

GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/mlSingapore · 216 mg/ml · injection · Fresenius Kabi (Singapore) Pte LTD

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Glycerophosphate
Strength: 50 MG / AMP + 2 MG / AMP + 200 MG / AMP
Dosage form: Liquid
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1979
Registration: DIN 00481378
Marketing authorisation holder: Laboratoires Cortunon INC.
Supply: NON-PRESCRIPTION DRUGS